Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

NCT00313599 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Brain and Central Nervous System Tumors
Breast Cancer
Esophageal Cancer
Extragonadal Germ Cell Tumor
Gastric Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer

Interventions

DRUG: lapatinib
DRUG: paclitaxel

Sponsor

University of California, San Francisco

Collaborators

[object Object]